by Cal Strode | Aug 17, 2022
Launched in June of 2015, ExCellThera is a clinical-stage biotechnology company making strides in developing robust and cost-effective processes for growing blood stem cells for therapeutic use, backed by award-winning proprietary technology. The company was founded...
by Stacey Johnson | Nov 12, 2021
In 2016 I shared a list of podcasts that I thought Signals’ readers might enjoy. I think it’s definitely time to update that list, and I’m excited to tell you about a new podcast that’s about to launch: Commercializing Living Therapies with CCRM. Commercializing...
by Lyla El-Fayomi | Jun 30, 2021
“Regenerative medicine news under the microscope” is a new monthly feature highlighting big stories in stem cell research. I will sample the latest and greatest findings in recent press and package them into a single post. This month was packed with interesting...
by Stacey Johnson | Jun 25, 2021
Back in November 2020, California voters approved Proposition 14. That means US$5.5B is being directed to the California Institute for Regenerative Medicine (CIRM) to support promising cell and gene therapy research so the organization can continue the important work...
by Stacey Johnson | Feb 12, 2021
Canada is a country that prides itself on “punching above its weight.” We use this metaphor all the time to describe how we succeed in given situations despite our limitations. Although it’s a cliché, it remains a point of pride for Canadians. For example, in the...
Comments